Larimar Therapeutics (LRMR) Shares Issued: 2015-2020
Historic Shares Issued for Larimar Therapeutics (LRMR) over the last 4 years, with Dec 2020 value amounting to $242,000.
- Larimar Therapeutics' Shares Issued fell 93.00% to $242,000 in Q4 2020 from the same period last year, while for Dec 2020 it was $18.1 million, marking a year-over-year decrease of 6.66%. This contributed to the annual value of $161.8 million for FY2024, which is 539253.33% up from last year.
- According to the latest figures from Q4 2020, Larimar Therapeutics' Shares Issued is $242,000, which was up 279.26% from -$135,000 recorded in Q3 2020.
- Over the past 5 years, Larimar Therapeutics' Shares Issued peaked at $64.2 million during Q3 2018, and registered a low of -$135,000 during Q3 2020.
- Its 3-year average for Shares Issued is $9.3 million, with a median of $3.0 million in 2019.
- Its Shares Issued has fluctuated over the past 5 years, first surged by 80,166.25% in 2018, then slumped by 101.36% in 2020.
- Larimar Therapeutics' Shares Issued (Quarterly) stood at $165,000 in 2016, then plummeted by 51.52% to $80,000 in 2017, then soared by 80,166.25% to $300,000 in 2018, then surged by 1,051.67% to $3.5 million in 2019, then tumbled by 93.00% to $242,000 in 2020.
- Its Shares Issued was $242,000 in Q4 2020, compared to -$135,000 in Q3 2020 and $8.4 million in Q2 2020.